Patients evaluated by a pelvic floor specialist (either urogynecologist or urologist) at the University of Miami with plans to undergo urethral bulking with Bulkamid for stress urinary incontinence or mixed urinary incontinence (stress predominant).
Negative testing for UTI in pre-procedural work-up, including either negative urine culture or urine dip negative for infection (infection is defined as the presence of nitrites and/or pyuria with \>1+ leukocyte esterase on dipstick or \>5 WBC/HPF).
Post-void residual volume of 150 mL or less (measured by either catheterization or bladder scan) before the procedure
Fluent in English or Spanish
Able and willing to provide informed consent
You may not be if
Contraindications to both oral antibiotics including antibiotic allergies or significant renal disease (GFR \<30)
Patient undergoing additional pelvic organ prolapse procedures or other urologic procedures concomitantly that also involve insertion \[KB2.1\]of a foreign object
Recurrent UTIs, defined as 3 or more UTIs within the past 12 months or 2 UTIs within the past 6 months
Patients currently taking daily antibiotic prophylaxis for any reason
Patients with immunosuppression due to underlying medical conditions
Patients who are pregnant
Recent antibiotic treatment within one week of the procedure
Unable or unwilling to provide informed consent or complete study procedures
Clareo Health | Prophylactic Antibiotics for Outpatient Urethral Bulking
